MIM
TDOC icon

Macroview Investment Management’s Teladoc Health TDOC Stock Holding History

Macroview Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50
Closed -$755 – 682
2024
Q1 		$755 Buy
+50
New +$907 ﹤0.01% 577
2022
Q3 		– Sell
-50
Closed -$2K – 519
2022
Q2 		$2K Hold
50
– – ﹤0.01% 378
2022
Q1 		$4K Hold
50
– – 0.01% 327
2021
Q4 		$5K Sell
50
-4
-7% -$478 0.01% 285
2021
Q3 		$7K Hold
54
– – 0.01% 266
2021
Q2 		$9K Buy
54
+11
+26% +$1.78K 0.01% 192
2021
Q1 		$8K Sell
43
-19
-31% -$4.41K 0.01% 176
2020
Q4 		$12K Buy
62
+32
+107% +$6.51K 0.02% 136
2020
Q3 		$7K Buy
30
+15
+100% +$3.18K 0.01% 148
2020
Q2 		$3K Buy
+15
New +$2.63K 0.01% 228

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Macroview Investment Management's TDOC Position: Q2 2024 in Review

Macroview Investment Management sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 50 shares — an estimated $755 sold.

Macroview Investment Management first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $12K in Q4 2020. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Macroview Investment Management reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Macroview Investment Management sold 50 Teladoc Health shares in Q2 2024, an estimated $755.
  • Macroview Investment Management first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Macroview Investment Management's Teladoc Health position peaked at $12K in Q4 2020.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Macroview Investment Management's 13F filing for Q2 2024, filed 23 Jul 2024.